Agonist News and Research

RSS
Dominion validates clinical urine drug monitoring assay to detect metabolites of 'herbal incense' product compounds

Dominion validates clinical urine drug monitoring assay to detect metabolites of 'herbal incense' product compounds

Phase III trial results of lixisenatide for type 2 diabetes presented at 46th EASD

Phase III trial results of lixisenatide for type 2 diabetes presented at 46th EASD

Tiotropium bromide shows potential as an alternative asthma treatment

Tiotropium bromide shows potential as an alternative asthma treatment

FDA reviews Actos drug for bladder cancer risk

FDA reviews Actos drug for bladder cancer risk

Phase II clinical trial shows GTx-758 reduces serum free testosterone

Phase II clinical trial shows GTx-758 reduces serum free testosterone

AMRI selects compound for advanced preclinical testing in treatment of IBS

AMRI selects compound for advanced preclinical testing in treatment of IBS

TransPharma Medical completes ViaDerm-GLP1 agonist Phase 1a trial for type II diabetes

TransPharma Medical completes ViaDerm-GLP1 agonist Phase 1a trial for type II diabetes

Meditrina licensor AstraZeneca granted US allowance of patent for endometriosis treatment

Meditrina licensor AstraZeneca granted US allowance of patent for endometriosis treatment

Seaside reports positive data from STX209 Phase 2 study in ASD

Seaside reports positive data from STX209 Phase 2 study in ASD

Santarus, VeroScience enter agreement to commercialize CYCLOSET drug for type 2 diabetes

Santarus, VeroScience enter agreement to commercialize CYCLOSET drug for type 2 diabetes

Hemispherx Biopharma to present clinical data on XMRV retrovirus at International Workshop

Hemispherx Biopharma to present clinical data on XMRV retrovirus at International Workshop

Discovery of omega-3 fatty acid molecular mechanism paves way for development of dietary remedy for diabetes

Discovery of omega-3 fatty acid molecular mechanism paves way for development of dietary remedy for diabetes

Pharmacor 2010 findings predict COPD drug market rise to $13 billion in 2019

Pharmacor 2010 findings predict COPD drug market rise to $13 billion in 2019

Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list   for depression treatment

Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list for depression treatment

Merck's initiation of IMO-2055 Phase 1b clinical trial in SCCHN triggers €3.0M milestone payment to Idera

Merck's initiation of IMO-2055 Phase 1b clinical trial in SCCHN triggers €3.0M milestone payment to Idera

Naringenin from grape fruits initiates increased fatty acid oxidation, inhibits vLDL production

Naringenin from grape fruits initiates increased fatty acid oxidation, inhibits vLDL production

Tranzyme Pharma to present ulimorelin Phase 2 data at NGM Meeting

Tranzyme Pharma to present ulimorelin Phase 2 data at NGM Meeting

Physicians decrease LABA/ICS combination therapy for asthma treatment: Survey

Physicians decrease LABA/ICS combination therapy for asthma treatment: Survey

Hospira Japan receives approval for long term use of Precedex IV sedative

Hospira Japan receives approval for long term use of Precedex IV sedative

Palatin reports positive results from bremelanotide Phase 1 trial for sexual dysfunction

Palatin reports positive results from bremelanotide Phase 1 trial for sexual dysfunction

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.